References cited in

Ref cited in

1. Bacterial Infections of Humans: Epidemiology and Control - Google Books Result

by Alfred S. Evans, Philip S. Brachman - 1998 - Medical - 888 pages

Kher, SK, Rao, MR, Raghunath. D., et ai, HLA-linked genetic control of leprosy. Med. J. Armed Forces India 48:116- 118 (1992).

2. Human leucocyte antigen and insulin dependent diabetes mellitus.

Cited in J Assoc Physicians India 1991 Jul; 39(7)540-3.

M M Gupta

D Raghunath

S K Kher

A P Radhakrishnan

Department of Medicine, Armed Forces Medical College, Pune.

HLA typing was done in 25 cases of insulin dependent diabetes mellitus (IDDM) and compared with 60 healthy controls. There was a significantly increased frequency of HLA B-8, HLA B-12 and HLA DR-3 in IDDMO. The odds ratio (relative risk) of developing IDDM for HLA B-8 was 4.42 (p less than 0.10), for HLA B-12 was 3.56 (p less than 0.10) and for HLA DR3 9.75 (p less than 0.001). There was no correlation of HLA specificity with complications of diabetes.


PMID: 1724775

The full text of this article may be accessible through PubMed at:

3. Amebiasis Newsletter

Editors: C. G. Clark, LSHTM, London, England, L. S. Diamond, NIH, Bethesda MD, USA,

M. Espinosa Cantellano, A. Martínez-Palomo, CINVESTAV-IPN, México DF

Nº 13, Spring 1997

Correspondence should be sent to:

Dr. C. Graham Clark, Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, England, G.B.

OR: Dra. Martha Espinosa Cantellano, Departamento de Patología Experimental, CINVESTAV- IPN, Aptdo. Postal 14-740, CP 07000 México D.F., México

4. XIII Seminar on Amebiasis

The XIII Seminar on Amebiasis was held January 29-31, 1997 in Mexico City with an unprecedented attendance from both national and international institutions. During the 3-day meeting, a tight schedule was kept and 58 oral and 71 poster presentations were made. Abstracts of all presentations can be found in a special issue of the Archives of Medical Research (volume 28, pages 1-329, 1997). The security services at El Colegio Nacional reported an attendance of over 500 people every day. Of these, a total of 377 registrations were filed: 121 from presenting authors, 71 from co-authors of papers presented at the meeting, and 185 from the general public. Most registrations corresponded to people living in Mexico City (249), followed by overseas participants (66), and by persons travelling from different states of Mexico (62). Congratulations to all for a fruitful meeting!

5. WHO/PAHO/UNESCO Consultation of Experts on Amoebiasis

On the 28th and 29th of January immediately prior to the XIII Seminar on Amebiasis a meeting sponsored by WHO, PAHO & UNESCO took place the purpose of which was to examine the recent evidence for the existence of two species within what had been called Entamoeba histolytica and to make recommendations based on their conclusions. Seventeen experts from around the world along with Dr. Lorenzo Savioli, representing the World Health Organization, and Dr. Gabriel Schmunis, representing the Pan American Health Organization, were in attendance. The resulting document, which was unanimously approved by all participants, will be published in a WHO Weekly Bulletin in the near future. Some of the results of the meeting are as follows:

The existence of the two species, E. histolytica and E. dispar, was recognized and the name E. histolytica should in future be used only in reference to the species capable of causing invasive disease (formerly known as `pathogenic E. histolytica'). When differentiation between the two species is not possible for technical reasons the infection should be reported as `E. histolytica/E. dispar'. The definition of amoebiasis is unchanged and refers to infection with E. histolytica (in the new sense) with or without clinical manifestations.

The participants also identified several priority areas for amebiasis research. These included improved methods for specific diagnosis of E. histolytica using technologies appropriate for developing countries, collection of accurate prevalence data, especially on asymptomatic E. histolytica infections, and molecular epidemiology studies. Recommendations for approaches to treatment were also made.

6. Recent Publications in Amebiasis

Abbas, Z., Ahmad, A. & Khan, A.H. (1997) Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in amoebic liver abscess. J. Infect. 34: 79-81.

Agundis Mata, C., Blanco, F., Toledo, J., Reta, F., Kumate, J. & Isibasi, A. (1996) Identification of a 35 kDa glycoprotein from Entamoeba histolytica by sera from patients with amoebic liver abscess and with mouse monoclonal antibody. Immunol. Investig. 25: 519-529.

Alagón, A., Cortés, A., Olvera, F., Olvera, A., González, A. & Lizardi, P. (1996) [Impact of new methods on the study of parasites. II. Design and construction of vectors for stable transformation of Entamoeba histolytica. (in Spanish)]. Gac. Méd. Méx. 132: 476-482.

Anand, A.C., Reddy, P.S., Salprasad, G.S. & Kher, S.K. (1997) Does non-dysenteric intestinal amoebiasis exist? Lancet 349: 89-92.

English Title: HIV infection in the armed forces: our approach to counselling.

Personal Authors: Punia, H., Kher, S. K.

Author Affiliation: Medical Journal Armed Forces India, c/o Armed Forces Medical College, Pune 411 040, India.

Editors: No editors

Document Title : Medical Journal Armed Forces India, 1993 (Vol. 49) (No. 2) 123-127

Abstract: Abstract Not Available


About CAB Abstracts

CAB Abstracts is a unique and informative resource covering everything from Agriculture to Entomology to Public Health. In April 2006 we published our 5 millionth abstract, making it the largest and most comprehensive abstracts database in its field.

Ref of Dr. Sudheer Kher's research work cited in


Kher SK (S K)

Latest Paper:

Lancet. 1997 Jan 11;349 (9045):89-92 8996420 (P,S,E,B)

Does non-dysenteric intestinal amoebiasis exist?

[My paper] A C Anand, P S Reddy, G S Saiprasad, S K Kher

Department of Medicine, Armed Forces Medical College, Pune, India.

BACKGROUND: Chronic abdominal pain and frequent bowel disturbance are common symptoms experienced by more than 15% of apparently healthy people. In areas endemic for Entamoeba histolytica infection, these symptoms are often diagnosed as non-dysenteric intestinal amoebiasis even though no causal relation between such symptoms and E histolytica has been established and clinical presentation of non-dysenteric intestinal amoebiasis and irritable bowel syndrome (IBS) is not distinct. This study was done to assess the clinical significance of E histolytica infection in causation of such symptoms. METHODS: Patients with symptoms suggestive of non-dysenteric intestinal amoebiasis were recruited from a survey to assess the prevalence of abdominal symptoms in the general population (group A; n = 78) and from medical outpatient clinics (group B; n = 66). Participants who had symptoms as well as symptom-free controls (group C; n = 100) were clinically examined and underwent stool examination, amoebic serology, colonoscopic examination, histopathological examination of colonoscopic biopsy samples, and a trial of antiamoebic therapy (only for participants with symptoms) with metronidazole and mebendazole. FINDINGS: There were no significant differences between the 144 patients with symptoms and the 100 symptom-free controls in the proportion with E histolytica in stools (26 [18%] vs 18 [18%]), serological evidence of E histolytica infection (61 [42%] vs 41 [41%]), colonoscopic abnormalities (five of 66 vs one of 33), or histopathological abnormalities (36 [49%] of 73 vs ten [30%] of 33). Cyst-positive and cyst-negative individuals showed no significant difference in serological evidence of E histolytic infection, histological abnormalities, or response to therapeutic trial with metronidazole. A diagnosis of IBS was suggested on the basis of consensus criteria and Kruis diagnostic index in 127 of 144 patients with symptoms. The diagnosis of non-dysenteric intestinal amoebiasis could be made in only one patient, who had relapse of symptoms within 6 weeks of antiamoebic therapy and therefore the relapse did not meet criteria for the diagnosis of non-dysenteric intestinal amoebiasis. More than 60% of cyst-positive as well as cyst-negative patients with symptoms showed either complete or partial response to treatment strategy for IBS. INTERPRETATION: Chronic bowel symptoms, such as pain in abdomen and frequent bowel disturbance, have no association with either past or present infection with E histolytica. Most patients with such symptoms are likely to have IBS. The clinical entity of non-dysenteric intestinal amoebiasis, if it exists, must be extremely rare.

Mesh-terms: Abdominal Pain :: etiology; Adolescent; Adult; Aged; Animals; Antibodies, Protozoan :: analysis; Child; Colonic Diseases, Functional :: etiology; Dysentery, Amebic :: complications;Dysentery, Amebic :: parasitology; Entamoeba histolytica :: immunology; Entamoeba histolytica :: isolation & purification; Female; Human; Intestinal Diseases :: etiology; Male; Mebendazole :: therapeutic use; Metronidazole :: therapeutic use; Middle Aged; Support, Non-U.S. Gov't;

8. J Assoc Physicians India. 1991 Jul ;39:540-3 1724775 (P,S,E,B)

Human leucocyte antigen and insulin dependent diabetes mellitus.

[My paper] M M Gupta, D Raghunath, S K Kher, A P Radhakrishnan

Department of Medicine, Armed Forces Medical College, Pune.

HLA typing was done in 25 cases of insulin dependent diabetes mellitus (IDDM) and compared with 60 healthy controls. There was a significantly increased frequency of HLA B-8, HLA B-12 and HLA DR-3 in IDDMO. The odds ratio (relative risk) of developing IDDM for HLA B-8 was 4.42 (p less than 0.10), for HLA B-12 was 3.56 (p less than 0.10) and for HLA DR3 9.75 (p less than 0.001). There was no correlation of HLA specificity with complications of diabetes.

Mesh-terms: Adolescent


File Format: PDF/Adobe Acrobat - View as HTML

J. Jena, B.N. Panda, S.K. Nema, S.K. Kher and S.C.. Tewari. Between January 1990 and March 1996, 114. (20%) out of 573 HIV seropositive patients in the ... - Similar pages - Note this

10. False positive ELISA results in human immunodeficiency virus ...

Rao MKK; Gupta RM; Sayal SK; Ohri VC; Kher SK. Reader, Armed Forces Medical College, Pune-411 040. False positive ELISA results in human immunodeficiency ... - 3k - Cached - Similar pages - Note this















  15. Blackwell Synergy - Clin Exp Immunol, Volume 149 Issue 3 Page 570









    1. Ohri VC, Rao MK, Banerjee K, Raghunath GD, Kher SK, Gupta RM, Nema SK, Singh L. Prevalence of antibodies to hepatitis C virus in hospitalized population subsets. Med J Armed Forces India. 1997;53(1):3-6. Cited in Current bibligraphies in Medicine, National Institute of Health, Management of Hepatitis C -2002, National Library of Medicine.

    2. Emerging antibiotic resistance in bacteria with special reference to India. D Raghunath, J. Biosci. 33(4), November 2008 page 589 ,, November 2008 page 589 , Raghunath D and Kher S K 1989 Antibiotic therapy of Salmonellosis. Editorial; Med.. J. Armed Forces India 45Med.. J. Armed Forces India 45, 3–4

Cited in 20 Publications as follows -

        • 1